Research use only. This compound is supplied for in-vitro laboratory research by qualified researchers. It is not for human or veterinary consumption and has not been evaluated by the FDA.
Buy more of this strength and the price comes down. The store applies it at checkout - there is nothing to enter.
Free US shipping on orders of $200 or more
Tell us the Report ID or Laboratory ID shown on the certificate, and what you observed. If independent testing shows a discrepancy against our published certificate, we refund the lot in full and pull it from sale pending investigation.
1
$140.00each
Tell us the Report ID or Laboratory ID shown on the certificate, and what you observed. If independent testing shows a discrepancy against our published certificate, we refund the lot in full and pull it from sale pending investigation.
Identifiers are published properties of the molecule. Values we cannot confirm are omitted rather than estimated.
IGF-1 LR3 is an eighty-three-residue analogue of human insulin-like growth factor I carrying two deliberate changes. They are a thirteen-residue N-terminal extension, and arginine in place of glutamate at position 3 of the growth-factor chain.
Both modifications are documented in the paper that introduced the construct, Francis and colleagues in the Journal of Molecular Endocrinology in 1992, which defines it as methionyl porcine growth hormone residues 1 to 11 followed by valine and asparagine, joined to the substituted growth factor. The extension reads MFPAMPLSSLFVN. FDA GSRS registers the same thing under UNII M9L22Y19H9 and its systematic name encodes it independently.
The substitution is described in insulin-like-growth-factor numbering, and that is a numbering trap worth stating: the arginine sits at position 3 of the seventy-residue growth-factor chain, which is position 16 of the eighty-three-residue molecule actually supplied. Residues 14 to 83 are otherwise identical to the mature growth factor as annotated on UniProt P05019.
Three disulfides fix the fold, connecting residues 19 to 61, 31 to 74, and 60 to 65 in the numbering of this chain; the bonds were originally located by mass spectrometry by Raschdorf and colleagues in 1988. Francis and colleagues report that the hydrophobic extension makes correct oxidative folding easier than in the unextended protein, which is a manufacturing property rather than a property of the folded molecule.
No molecular weight or molecular formula is printed on this page, and the reason is specific. FDA GSRS publishes both but flags each as an estimate, and its protein estimator is measurably high: it returns a figure for the native growth factor about three daltons above the accepted value. The two numbers circulating in the trade, near 9111 and near 9118, are not two candidate masses but the same molecule fully oxidised and fully reduced. Until a figure with a stated oxidation state comes from a measurement rather than an estimator, printing one here would put a number next to a structure that disagrees with it.
This is routinely confused with two neighbouring molecules and is neither. Native insulin-like growth factor I, registered as mecasermin, is seventy residues with glutamate at position 3 and no extension. IGF-1 DES, CAS 112603-35-7, is sixty-seven residues: the native chain with its first three residues removed. One is an extension plus a substitution, the other is a truncation; they share no mass, formula, CAS number or residue count.
The molecule has no tryptophan, three tyrosines and six phenylalanines, so absorbance at 280 nm is usable but weak. Three methionines and six cysteines, all of the latter in disulfides, are the oxidation-relevant residues. Its receptor is IGF1R (UniProt P08069); Francis and colleagues also report cross-reaction with the insulin receptor (UniProt P06213) at high concentration in a hepatoma assay, and reduced association with insulin-like-growth-factor binding proteins, which is the stated basis for the construct's behaviour in cell lines that secrete them.
Background
IGF-1 LR3 is an eighty-three-residue analogue of insulin-like growth factor I introduced by Francis and colleagues in 1992. It adds a thirteen-residue N-terminal extension (MFPAMPLSSLFVN) and carries arginine in place of glutamate at position 3 of the growth-factor chain, which is position 16 of the supplied molecule. Three disulfides fix the fold. Its receptor is IGF1R, with cross-reaction at the insulin receptor reported at high concentration and reduced association with insulin-like-growth-factor binding proteins.
Specifications
Supplied as
Lyophilized powder
Available strengths
1mg
CAS number
143045-27-6
Storage
Store lyophilized at -20C, protected from light and moisture.
Intended use
In-vitro laboratory research only
Storage & handling
Lyophilized
Store lyophilized at -20C, protected from light and moisture. The dominant liability is not chemical but conformational: the three disulfides can mispair, and a scrambled isomer is the expected principal related substance rather than a hydrolysis fragment. Hober and colleagues characterised the disulfide-exchange folding of insulin-like growth factor I in Biochemistry in 1992, and the same chemistry applies here. Three methionines give a secondary oxidation route to the sulfoxide. Avoid reducing agents, chelate trace metal, and prepare working solutions fresh; the hydrophobic N-terminal extension raises aggregation risk relative to the unextended protein..
Reconstituted
Refrigerate after reconstitution and use within the period appropriate to the material.
Handling notes
Store the lyophilized material at -20C, protected from light and moisture.
The dominant liability is disulfide mispairing, so a scrambled isomer is the expected principal related substance; avoid reducing agents.
Three methionines give a secondary oxidation route to the sulfoxide, so chelate trace metal.
The hydrophobic N-terminal extension raises aggregation risk; prepare working solutions fresh.
Three tyrosines and no tryptophan make absorbance at 280 nm usable but weak.
Safety & handling
Bench handling, not a dosing guide.
Intended use
Supplied strictly as a laboratory research material for in-vitro study by qualified researchers. Not for human or veterinary use, not for ingestion or injection, and not for any clinical or diagnostic application.
Personal protective equipment
Handle with gloves, eye protection and a laboratory coat. Weigh and transfer lyophilized powder in a ventilated enclosure to avoid generating an inhalable dust.
Reconstitution
Reconstitute against the diluent and volume appropriate to your protocol, adding solvent slowly down the vial wall rather than directly onto the pellet. Do not shake. This is a handling note, not a dosing guide.
Storage after opening
Once reconstituted, refrigerate and use within the period appropriate to the material. Avoid repeated freeze-thaw cycles, which degrade peptides faster than continuous storage at the listed temperature.
Disposal
Dispose of material and containers in accordance with your institution's chemical waste procedures and applicable local regulations.
Also sold as part of a set
5mg
10mg
1mg
10ml
Growth & Secretagogue · 4 vials
CJC-1295 (no DAC), Ipamorelin and IGF-1 LR3 Set
A 5mg and a 10mg secretagogue-class vial and a 1mg IGF-1 LR3 vial, plus water.
On its own this set comes to $254.97 at checkout: $45.00 Bundle & Save is taken off there.
CJC-1295 without DAC at 5mg, Ipamorelin at 10mg, IGF-1 LR3 at 1mg and a 10ml bacteriostatic water vial. The catalogue also sells CJC-1295 and Ipamorelin as a single pre-blended vial; this set is the opposite of that, giving you separate lyophilised vials so each compound can be reconstituted and handled on its own.
CJC-1295 without DAC and Ipamorelin belong to the growth-hormone secretagogue class; IGF-1 LR3 is an 83-residue growth-factor analogue. All three are filed under Growth & Secretagogue in this catalogue.
Adds 4 separate cart lines. Remove any one of them in the cart.
Supplied as a lyophilized powder for in-vitro laboratory research only. No statement on this page describes an application, benefit, dose, route or outcome. Descriptions are structural and mechanistic, and reference data such as CAS numbers and molecular formulas is published information about the compound itself, provided for identification. The certificate shown above is the testing laboratory's report 2607210501 for this strength; its results are for that report only and are not averaged across the product line.